What Is the Spire Healthcare Deal Worth?
The consortium has agreed to pay 250 pence per Spire Healthcare share.
Based on the agreed terms, the transaction values Spire Healthcare's share capital at approximately £1.026 billion, or around $1.39 billion based on the exchange rate cited in the announcement.
The offer represents a 66% premium to Spire Healthcare's market capitalisation on May 13, the day before the company disclosed that it had received a takeover proposal.
That premium makes the transaction significant for shareholders who have been following the company's strategic review and takeover discussions.
Who Is Buying Spire Healthcare?
The takeover consortium includes funds managed by:
- Toscafund Asset Management
- Three Hills
- Ares
Toscafund has been at the centre of the takeover discussions and was already one of Spire Healthcare's largest shareholders.
The consortium has been working on financing and transaction documentation following the original proposal earlier in 2026.
Why the Deal Took Months to Complete
The takeover did not happen immediately after the original proposal.
Spire Healthcare had previously disclosed a possible cash offer of 250 pence per share from funds advised by Toscafund. The proposal was subject to several conditions, including due diligence, financing and the completion of definitive transaction documents.
The deadline for Toscafund to either make a firm offer or walk away was extended several times.
In its September 4 announcement, Spire said Toscafund had completed its due diligence and had substantially completed work toward a recommended 250-pence-per-share offer. The transaction documentation and financing documentation were described as near-final at that stage.
What Does Spire Healthcare Do?
Spire Healthcare is one of the UK's major independent private healthcare groups.
The company operates 38 hospitals and more than 55 clinics across England, Wales and Scotland.
It works with more than 8,800 consultants and provides healthcare services to private patients, NHS patients, employers and people covered by private medical insurance.
The company says it treated more than 1.36 million inpatients, outpatients, day-case patients and workplace health clients in 2025.
Why Is the Takeover Important?
The transaction is significant because Spire operates a large network of private healthcare facilities across the UK.
Private healthcare providers have been navigating changing demand, NHS activity, medical insurance trends, operating costs and investment requirements.
For the new owners, acquiring Spire provides exposure to an established healthcare network with hospitals, clinics, specialist services and relationships with medical consultants.
For shareholders, the 250-pence-per-share offer provides a substantial premium compared with the company's pre-offer market value.
What Happens Next?
The takeover will now move through the next stages required to complete the transaction.
Shareholders and the market will receive further information about the terms, conditions and timetable through the company's regulatory announcements.
The final completion of the transaction will remain subject to the applicable takeover process and required conditions.
The Bigger Picture
The Spire Healthcare takeover highlights the continued interest of investment groups in established healthcare businesses.
Healthcare assets can be attractive to investors because demand for medical treatment tends to remain significant even when broader economic conditions change.
For Spire, the transaction could mark a new phase after years of expanding its hospital network, developing additional healthcare services and strengthening its position across the UK private healthcare market.
The £1.026 billion deal therefore represents more than a change in ownership. It could also shape the company's investment strategy, operations and growth priorities in the years ahead.